Sanjay Srivastava

Dr. Sanjay K. Srivastava is a Professor of Biomedical Sciences at Texas Tech University Health Sciences Center (TTUHSC), Amarillo, Texas, specializing in cancer biology, cell signaling and nutritional chemoprevention. Dr. Srivastava served as an Assistant Professor in the Department of Pharmacology, University of Pittsburgh School of Medicine, and did his post-doc from University of Texas Medical Branch at Galveston, Texas. He received a M.S. in Biochemistry from Lucknow University and a Ph.D. in Biochemical Toxicology from Industrial Toxicology Research Center, India. Dr. Srivastava is funded by grants from the National Cancer Institute, NIH. He has authored/co-authored more than 100 research papers and book chapters and is in the editorial board of several journals. Dr. Srivastava has been the recipient of several awards including TTUHSC “President’s Excellence in Research Award”. His research has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News etc.

2books edited

1chapters authored

Latest work with IntechOpen by Sanjay Srivastava

This book provides the reader with an overall understanding of the biology of pancreatic cancer, hereditary, complex signaling pathways and alternative therapies. The book explains nutrigenomics and epigenetics mechanisms such as DNA methylation, which may explain the etiology or progression of pancreatic cancer. Book also summarizes the molecular control of oncogenic pathways such as K-Ras and KLF4. Since pancreatic cancer metastasizes to vital organs resulting in poor prognosis, special emphasis is given to the mechanism of tumor cell invasion and metastasis. Role of nitric oxide and Syk kinase in tumor metastasis is discussed in detail. Prevention strategies for pancreatic cancer are also described. The molecular mechanisms of the anti-cancer effects of curcumin, benzyl isothiocyante and vitamin D are discussed in detail. Furthermore, this book covers the basic mechanisms of resistance of pancreatic cancer to chemotherapy drugs such as gemcitabine and 5-flourouracil.

Go to the book